Loss of PTEN (phosphatase and tensin homolog), a commonly altered tumor suppressor gene in prostate cancer, was analyzed in prostatic adenocarcinoma specimens from patients who subsequently developed biochemical recurrence. This evidence concerns the gene PTEN and prostate cancer.